20
Participants
Start Date
March 31, 2007
Primary Completion Date
August 31, 2011
Study Completion Date
December 31, 2011
Clofarabine with Busulfan
Clofarabine 40 mg/m2 IV QD × 5 days Busulfan (Busulfex™) 3.2 mg/kg IV QD × 2 days
Baylor University Medical Center, Dallas
Lead Sponsor
Genzyme, a Sanofi Company
INDUSTRY
Baylor Research Institute
OTHER